ARCEDE PHARMA
Arcede Pharma provides improved treatments for chronic respiratory diseases through new, innovative and patent protected substances.
ARCEDE PHARMA
Social Links:
Industry:
Biopharma Biotechnology
Founded:
2022-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.arcedepharma.com
Total Employee:
1+
Status:
Active
Total Funding:
877.5 K SEK
Technology used in webpage:
Euro Person Schema Google Google Cloud Gravatar Profiles Pound Sterling YouTube
Similar Organizations
Cimeio Therapeutics
Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.
Enterin
Philadelphia-based biotechnology company .
EpiVario
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
iECURE
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
NJ Bio
NJ Bio provides integrated chemistry and biology services to clients.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Transcenta
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.
Current Employees Featured
Investors List
Swelife
Swelife investment in Grant - Arcede Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2023-12-21 | BioStock: Arcede Pharma appoints acting CEO |
Official Site Inspections
http://www.arcedepharma.com
- Host name: 252.254.228.35.bc.googleusercontent.com
- IP address: 35.228.254.252
- Location:
- Latitude: 47
- Longitude: 8
- Timezone: Europe/Vaduz
More informations about "Arcede Pharma"
About us | Arcede Pharma
Arcede Pharma develops new patent-protected drug candidates with focus on chronic obstructive pulmonary disease (COPD) and severe asthma.See details»
Arcede Pharma - Crunchbase Company Profile & Funding
Arcede Pharma provides improved treatments for chronic respiratory diseases through new, innovative and patent protected substances.See details»
Investors | Arcede Pharma
Arcede Pharma (publ) primarily develops drug candidates with the goal of launching drugs to treat chronic obstructive pulmonary disease (COPD) and severe asthma.See details»
Arcede Pharma Overview | SignalHire Company Profile
Summary Aiming to provide improved treatments for chronic respiratory diseases through new, innovative and patent protected substances, thereby reducing suffering and ameliorating โฆSee details»
Arcede Pharma AB - Company Profile and News - Bloomberg โฆ
Company profile page for Arcede Pharma AB including stock price, company news, executives, board members, and contact informationSee details»
Arcede Pharma AB (ARCEDE) - Investing.com
This page offers an in-depth profile of Arcede Pharma AB, including a general overview of the company's business and key management.See details»
Arcede Pharma AB - Drug pipelines, Patents, Clinical trials - Synapse
Apr 19, 2024 Explore Arcede Pharma AB with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Immune System Diseases, Technology Platform:Small molecule ...See details»
Company Arcede Pharma AB Deutsche Boerse AG
Dec 31, 2021 Arcede Pharma AB: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Deutsche Boerse AG: โฆSee details»
Arcede Pharma: Contact Details and Business Profile - RocketReach
Arcede Pharma is a Biotechnology Research company_reader located in SE with 3 employees. Find top employees, contact details and business statistics at RocketReach.See details»
Arcede Pharma - LinkedIn
Arcede Pharma | 214 followers on LinkedIn. Aiming to provide improved treatments for chronic respiratory diseases through new, innovative drug substances | Aiming to provide improved โฆSee details»
Arcede Pharma AB - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Arcede Pharma AB of Stockholm, Stockholm. Get the latest business insights from Dun & Bradstreet.See details»
BioStock: Arcede Pharmaโs RCD405 well tolerated - Cision News
Arcede Pharma develops new patent-protected drug candidates with focus on chronic obstructive pulmonary disease (COPD) and severe asthma with the aim to improve quality of life, reduce โฆSee details»
Arcede Pharma - Products, Competitors, Financials, Employees ...
Arcede Pharma Unclaimed arcedepharma.com Overview & Products Financials Founded Year 2022 Stage IPO | IPO Date of IPO 6/29/2022 Market Cap 0.00B Revenue $0000 ViewSee details»
Arcede Pharma - Cision News
Arcede Pharma develops new patent-protected drug candidates with focus on chronic obstructive pulmonary disease (COPD) and severe asthma with the aim to improve quality of life, reduce โฆSee details»
R&D | Arcede Pharma
The primary focus of our project portfolio is to develop new treatments for COPD and severe asthma.See details»
Arcede Pharma AB_ๆ่่ตๆๆฐๆ ๅต_ๆฉ็ตๅป่ฏ (ๅ่ฏ่ไบ)
Arcede Pharma AB, a spin out of Respiratorius AB was founded in 2022 is developing new patent-protected drug candidates focusing on chronic obstructive pulmonary disease and โฆSee details»
Arcede Pharma AB: Shareholders Board Members Managers and โฆ
Dec 31, 2021 Arcede Pharma AB: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | NORDIC GROWTH โฆSee details»
News and presentations | Arcede Pharma
June 10, 2022 Arcede Pharma at BioStock Life Science Spring Summit 2022See details»
News Archives | Arcede Pharma
Https://arcedepharma.com/wp-content/uploads/2023/03/[email protected]://arcedepharma.com/wp โฆSee details»